These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7500688)

  • 1. [Acarbose and diabetes. Slight improvement or authentic therapeutic progress?].
    Costa B
    Med Clin (Barc); 1995 Sep; 105(9):341-3. PubMed ID: 7500688
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
    Calle-Pascual A; Garcia-Honduvilla J; Martin-Alvarez PJ; Calle JR; Maranes JP
    Diabetes Metab; 1996 Jun; 22(3):201-2. PubMed ID: 8697309
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-glucosidase inhibitors in diabetes. Introduction.
    Kruseman AC; Sels JP; Wolffenbuttel BH
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():1. PubMed ID: 8001619
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent progress in the treatment of diabetes mellitus.
    Mirouze J
    Adv Nephrol Necker Hosp; 1986; 15():307-27. PubMed ID: 3082115
    [No Abstract]   [Full Text] [Related]  

  • 6. [New hope for diabetics?].
    Becker R
    ZFA (Stuttgart); 1982 Sep; 58(26):1420-1. PubMed ID: 7180125
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acarbose and insulin dependent diabetes, type 1].
    Gabriel Botella F; Galindo Puerto MJ
    An Med Interna; 1996 Dec; 13(12):618. PubMed ID: 9063950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of acarbose in the treatment of diabetes mellitus].
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 10. Acarbose for diabetes mellitus.
    Med Lett Drugs Ther; 1996 Feb; 38(967):9-10. PubMed ID: 8559114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement in diabetes therapy. Interview by Heike E. Nähtke].
    Mehnert H
    Fortschr Med; 1990 Sep; 108(27):72, 75. PubMed ID: 2227754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of acarbose on intestinal disaccharidase: review of its therapeutic potential].
    Sternberg A; Wagner Y; Fireman Z
    Harefuah; 1994 May; 126(9):527-9. PubMed ID: 8034269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acarbose, a glucosidase inhibitor: a new therapeutic principle in diabetes mellitus].
    Hermansen K; Thomsen CH
    Ugeskr Laeger; 1996 Apr; 158(18):2564-8. PubMed ID: 8686016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acarbose in the metabolic control of infanto-juvenile onset diabetes mellitus. Medium-term results].
    Martí Colomer J; Tur Cotaina MD; Martin Baena J
    An Med Interna; 1995 Aug; 12(8):382-7. PubMed ID: 8924528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 16. [The "STOP NIDDM" program--can diabetes in the aged be prevented? An international long-term study revisited; does Acarbose delay or prevent the manifestations of type II diabetes].
    Dtsch Med Wochenschr; 1997; 122(38 Suppl):1-4. PubMed ID: 9339148
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of adult diabetes (type II)].
    Jahnke K
    Verh Dtsch Ges Inn Med; 1981; 87():25-34. PubMed ID: 7331453
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
    Phillips BB
    Pharm Pract Manag Q; 1997 Oct; 17(3):21-31. PubMed ID: 10173308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a long-term acarbose therapy on the metabolic control of sulphonylurea-treated diabetic patients.
    Sachse G; Laube H; Mäser E; Federlin K
    Diabetologia; 1982 Mar; 22(3):221. PubMed ID: 7075921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.